Epidemiology and susceptibility of pathogenic bacteria responsible for upper respiratory tract infections in pet rabbits

Veterinary Microbiology
S RougierM Vallé

Abstract

For 8 months, 121 pet rabbits of more than 2 months old were included in an epidemiological study aimed at determining the nature, prevalence and bacteriological susceptibility of pathogenic bacteria responsible for upper respiratory tract disease ("snuffles"). All rabbits presented with nasal discharge and sneezing at inclusion and had not received any antibiotics in the 30 days prior to the study. Nasal samples were taken from all the rabbits before they received any treatment. Isolation of bacterial strains, susceptibility testing by disk diffusion for marbofloxacin, enrofloxacin, danofloxacin, gentamicin, oxytetracycline, doxycycline, cefalexin, trimethoprim-sulfamethoxazole, and marbofloxacin MIC determination for each pathogenic bacterium were also performed. The main bacterial strains isolated were Pasteurella multocida (54.8%), Bordetella bronchiseptica (52.2%), Pseudomonas spp. (27.9%) and Staphylococcus spp. (17.4%). Snuffles was mainly due to a polybacterial infection, and the most frequently found combination was P. multocida and B. bronchiseptica (28.9% of rabbits). Marbofloxacin was shown to be the most effective agent against all bacterial strains (between 87.8% and 100% susceptibility according to strain) except...Continue Reading

References

Oct 1, 1990·Nihon juigaku zasshi. The Japanese journal of veterinary science·E KawamotoT Maruyama
May 1, 1990·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·W B ChungL R Bäckström
Mar 7, 2000·Veterinary Microbiology·A J SpeakmanR M Gaskell
Feb 28, 2001·The Veterinary Clinics of North America. Small Animal Practice·G P LanganC L Wardrip
Dec 27, 2002·The Journal of General and Applied Microbiology·Muthafar Hussain Al-HaddawiAbdul Rahman Sheikh-Omar
Apr 1, 2004·Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc·Amna B El TayebElisabeth J Angrick
Aug 25, 2004·International Journal of Antimicrobial Agents·D MeunierM Vallé
Sep 11, 2004·Clinical and Diagnostic Laboratory Immunology·Susan SanchezMargie D Lee
Nov 24, 2004·International Journal of Antimicrobial Agents·D MeunierM Valle
Nov 25, 2004·Antimicrobial Agents and Chemotherapy·Kristina KadlecStefan Schwarz

❮ Previous
Next ❯

Citations

Apr 2, 2009·American Journal of Veterinary Research·James W CarpenterRobert P Hunter
May 16, 2012·International Journal for Parasitology·Ashutosh K PathakIsabella M Cattadori
Mar 8, 2016·The Veterinary Clinics of North America. Exotic Animal Practice·Julie DeCubellis
Sep 8, 2009·The Veterinary Clinics of North America. Exotic Animal Practice·Angela M Lennox, Susan Kelleher
Jun 20, 2007·The Veterinary Clinics of North America. Exotic Animal Practice·Joanne Paul-Murphy
Apr 23, 2015·The Veterinary Clinics of North America. Exotic Animal Practice·Michelle G Hawkins
Dec 16, 2017·Journal of the American Veterinary Medical Association·Louden Wright, Christoph Mans
May 9, 2019·Journal of the American Veterinary Medical Association·Noémie M SummaGeraldine B Hunt
Oct 30, 2015·American Journal of Veterinary Research·Megan K WatsonMatthew S Johnston
Mar 7, 2020·The Veterinary Record·Alison P Wills
Sep 7, 2019·Animals : an Open Access Journal From MDPI·Shannon Roberts-SteelAlison P Wills
Aug 10, 2021·The Veterinary Clinics of North America. Exotic Animal Practice·Amber Lee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.